92 related articles for article (PubMed ID: 2366644)
1. Experimental cerebral infarction in the rat: utility of Gd-DOTA for MR imaging.
Van de Vyver FL; Peersman GV
Magn Reson Imaging; 1990; 8(3):333-40. PubMed ID: 2366644
[TBL] [Abstract][Full Text] [Related]
2. Detectability of small liver metastases with gadolinium BOPTA.
Runge VM; Lee C; Williams NM
Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
[TBL] [Abstract][Full Text] [Related]
3. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881
[TBL] [Abstract][Full Text] [Related]
4. Complementary use of T2- and postcontrast T1-weighted NMR images for the sequential monitoring of focal ischemic lesions in the rat brain.
Lanens D; Spanoghe M; Van Audekerke J; Van der Linden A; Dommisse R
Magn Reson Imaging; 1993; 11(5):675-83. PubMed ID: 8345782
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model.
Runge VM; Lee C; Iten AL; Williams NM
Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-DOTA enhanced MR imaging of intracranial lesions.
Parizel PM; Degryse HR; Gheuens J; Martin JJ; Van Vyve M; De La Porte C; Selosse P; Van de Heyning P; De Schepper AM
J Comput Assist Tomogr; 1989; 13(3):378-85. PubMed ID: 2723166
[TBL] [Abstract][Full Text] [Related]
7. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material.
Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
AJR Am J Roentgenol; 1994 Feb; 162(2):431-5. PubMed ID: 8310940
[TBL] [Abstract][Full Text] [Related]
8. [MRI of acute myocardial infarction with injection of Gd-DOTA (15 patients)].
Richoz B; Delcour C; Depelchin P; Lenaers A; Jacquemin C; Gusella P; Struyven J
Ann Radiol (Paris); 1990; 33(2):93-8. PubMed ID: 2221784
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model.
Runge VM
Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
[TBL] [Abstract][Full Text] [Related]
11. Volumetric assessment of myocardial viability in rats using 3D double contrast enhanced T1 and T2-weighted MRI.
Chapon C; Franconi F; Lemaire L; Marescaux L; Legras P; Denizot B; Le Jeune JJ
MAGMA; 2005 Dec; 18(6):302-8. PubMed ID: 16362430
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of acute cerebral infarction: experimental study with Gd-DTPA.
Hayakawa K; Yamashita K; Matsuda T; Miyake T; Ito H
Radiat Med; 1989; 7(2):58-65. PubMed ID: 2798931
[TBL] [Abstract][Full Text] [Related]
13. The use of Gd-DOTA in magnetic resonance imaging of experimentally induced mammary tumors.
Bonnet PA; Michel A; Fernandez JP; Cyteval C; Rifai A; Boucard M; Chapat JP; Lamarque JL
Magn Reson Imaging; 1990; 8(1):71-7. PubMed ID: 2325520
[TBL] [Abstract][Full Text] [Related]
14. Complementary use of T2-weighted and postcontrast T1- and T2*-weighted imaging to distinguish sites of reversible and irreversible brain damage in focal ischemic lesions in the rat brain.
Lanens D; Spanoghe M; Van Audekerke J; Oksendal A; Van der Linden A; Dommisse R
Magn Reson Imaging; 1995; 13(2):185-92. PubMed ID: 7739359
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
[TBL] [Abstract][Full Text] [Related]
16. MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium.
Jacquier A; Wendland M; Do L; Robert P; Corot C; Higgins CB; Saeed M
Contrast Media Mol Imaging; 2008; 3(3):112-9. PubMed ID: 18548477
[TBL] [Abstract][Full Text] [Related]
17. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
[TBL] [Abstract][Full Text] [Related]
18. Intraarticular tolerability and kinetics of gadolinium tetra-azacyclododecane tetraacetic acid.
Rahmouni A; Mathieu D; Chambon C; Dao TH; Hernigou P; Vasile N
Acad Radiol; 1995 May; 2(5):413-7. PubMed ID: 9419584
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
Colosimo C; Knopp MV; Barreau X; Gérardin E; Kirchin MA; Guézénoc F; Lodemann KP
Neuroradiology; 2004 Aug; 46(8):655-65. PubMed ID: 15205859
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
Fries P; Morr D; Müller A; Lux F; Tillement O; Massmann A; Seidel R; Schäfer T; Menger MD; Schneider G; Bücker A
Rofo; 2015 Dec; 187(12):1108-15. PubMed ID: 26361379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
